Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy - common ground for therapeutic trials and TNM subgroups

Autor: Ghavamian, R., Blute, M.L., Bergstralh, E.J., Slezak, J., Zincke, H.
Zdroj: Urology; 1999, Vol. 54 Issue: 1 p105-110, 6p
Databáze: Supplemental Index
Externí odkaz: